11.41
+0.3503(+3.17%)
Currency In USD
| Previous Close | 11.06 |
| Open | 11.32 |
| Day High | 11.44 |
| Day Low | 11.05 |
| 52-Week High | 11.48 |
| 52-Week Low | 6.55 |
| Volume | 5,674 |
| Average Volume | 29,330 |
| Market Cap | 56.62M |
| PE | 71.31 |
| EPS | 0.16 |
| Moving Average 50 Days | 10.12 |
| Moving Average 200 Days | 8.61 |
| Change | 0.35 |
If you invested $1000 in Daxor Corporation (DXR) 10 years ago, it would be worth $1,727.7 as of September 09, 2025 at a share price of $11.41. Whereas If you bought $1000 worth of Daxor Corporation (DXR) shares 5 years ago, it would be worth $760.69 as of September 09, 2025 at a share price of $11.41.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Daxor's Blood Volume Analysis Validated for COVID and Sepsis Patients in New Peer-Reviewed Pilot Study Published in the Journal of Critical Care
GlobeNewswire Inc.
Sep 04, 2025 12:00 PM GMT
Study Demonstrates That Clinical Assessments of Fluid Status Are Often Inaccurate, Highlighting the Urgent Need for BVA and Other More Reliable Tools in Landmark Pilot Study Oak Ridge, TN, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasda
Daxor Corporation to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire Inc.
Sep 03, 2025 12:00 PM GMT
Oak Ridge, TN, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh will present at the H.C. Wainwright 27th Annual Gl
Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter
GlobeNewswire Inc.
Sep 02, 2025 12:00 PM GMT
Oak Ridge, TN, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update in a Letter to Shareholders from CEO and President